Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Current Assets (2018 - 2025)

Volitionrx filings provide 11 years of Current Assets readings, the most recent being $2.1 million for Q4 2025.

  • On a quarterly basis, Current Assets fell 49.2% to $2.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 million, a 49.2% decrease, with the full-year FY2025 number at $2.1 million, down 49.2% from a year prior.
  • Current Assets hit $2.1 million in Q4 2025 for Volitionrx, up from $1.3 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $29.4 million in Q2 2021 to a low of $1.3 million in Q3 2025.
  • Median Current Assets over the past 5 years was $12.2 million (2023), compared with a mean of $13.7 million.
  • Biggest five-year swings in Current Assets: surged 79.54% in 2023 and later tumbled 81.44% in 2024.
  • Volitionrx's Current Assets stood at $22.0 million in 2021, then plummeted by 44.62% to $12.2 million in 2022, then surged by 79.54% to $21.9 million in 2023, then tumbled by 81.44% to $4.1 million in 2024, then plummeted by 49.2% to $2.1 million in 2025.
  • The last three reported values for Current Assets were $2.1 million (Q4 2025), $1.3 million (Q3 2025), and $3.3 million (Q2 2025) per Business Quant data.